Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Stressgen Biotechnologies Corp (SSB.TO)

BUY
New issue coming up so stock is drifting. Good phase 2 trials. Phase 3 trials can take a long time.
BUY
News on a product created a pop on the stock. Still early data. Could go higher.
BUY
Good technology. In phase 2 and 3trials.
PAST TOP PICK
(Was a top pick on Oct 16 down 27%) A favourite jr. biotech. Likes the project which is now in phase 3. Good price.
BUY
Very attractive at this price. Leading company in what they do. Well financed.
BUY
A good bet. A lot of support and good prospects
BUY
A favourite. Finished phase 2 trials Probably 3 years before its on the market
TOP PICK
Working on drug for treatment of Human Pathlonium virus
Showing 16 to 23 of 23 entries